Literature DB >> 28832877

Association of Lithium in Drinking Water With the Incidence of Dementia.

Lars Vedel Kessing1, Thomas Alexander Gerds2, Nikoline Nygård Knudsen3, Lisbeth Flindt Jørgensen4, Søren Munch Kristiansen5, Denitza Voutchkova4,5,6, Vibeke Ernstsen4, Jörg Schullehner4, Birgitte Hansen4, Per Kragh Andersen2, Annette Kjær Ersbøll3.   

Abstract

Importance: Results from animal and human studies suggest that lithium in therapeutic doses may improve learning and memory and modify the risk of developing dementia. Additional preliminary studies suggest that subtherapeutic levels, including microlevels of lithium, may influence human cognition. Objective: To investigate whether the incidence of dementia in the general population covaries with long-term exposure to microlevels of lithium in drinking water. Design, Setting, and Participants: This Danish nationwide, population-based, nested case-control study examined longitudinal, individual geographic data on municipality of residence and data from drinking water measurements combined with time-specific data from all patients aged 50 to 90 years with a hospital contact with a diagnosis of dementia from January 1, 1970, through December 31, 2013, and 10 age- and sex-matched control individuals from the Danish population. The mean lithium exposure in drinking water since 1986 was estimated for all study individuals. Data analysis was performed from January 1, 1995, through December 31, 2013. Main Outcomes and Measures: A diagnosis of dementia in a hospital inpatient or outpatient contact. Diagnoses of Alzheimer disease and vascular dementia were secondary outcome measures. In primary analyses, distribution of lithium exposure was compared between patients with dementia and controls.
Results: A total of 73 731 patients with dementia and 733 653 controls (median age, 80.3 years; interquartile range, 74.9-84.6 years; 44 760 female [60.7%] and 28 971 male [39.3%]) were included in the study. Lithium exposure was statistically significantly different between patients with a diagnosis of dementia (median, 11.5 µg/L; interquartile range, 6.5-14.9 µg/L) and controls (median, 12.2 µg/L; interquartile range, 7.3-16.0 µg/L; P < .001). A nonlinear association was observed. Compared with individuals exposed to 2.0 to 5.0 µg/L, the incidence rate ratio (IRR) of dementia was decreased in those exposed to more than 15.0 µg/L (IRR, 0.83; 95% CI, 0.81-0.85; P < .001) and 10.1 to 15.0 µg/L (IRR, 0.98; 95% CI, 0.96-1.01; P = .17) and increased with 5.1 to 10.0 µg/L (IRR, 1.22; 95% CI, 1.19-1.25; P < .001). Similar patterns were found with Alzheimer disease and vascular dementia as outcomes. Conclusions and Relevance: Long-term increased lithium exposure in drinking water may be associated with a lower incidence of dementia in a nonlinear way; however, confounding from other factors associated with municipality of residence cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28832877      PMCID: PMC5710473          DOI: 10.1001/jamapsychiatry.2017.2362

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  40 in total

1.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

Review 2.  The Putative Use of Lithium in Alzheimer's Disease.

Authors:  Gerwyn Morris; Michael Berk
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

Review 4.  Lithium: occurrence, dietary intakes, nutritional essentiality.

Authors:  Gerhard N Schrauzer
Journal:  J Am Coll Nutr       Date:  2002-02       Impact factor: 3.169

5.  Lithium in drinking water and suicide mortality.

Authors:  Nestor D Kapusta; Nilufar Mossaheb; Elmar Etzersdorfer; Gerald Hlavin; Kenneth Thau; Matthäus Willeit; Nicole Praschak-Rieder; Gernot Sonneck; Katharina Leithner-Dziubas
Journal:  Br J Psychiatry       Date:  2011-05       Impact factor: 9.319

6.  Lithium treatment and risk of dementia.

Authors:  Lars Vedel Kessing; Lars Søndergård; Julie Lyng Forman; Per Kragh Andersen
Journal:  Arch Gen Psychiatry       Date:  2008-11

7.  Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

Authors:  Moussa B H Youdim; Galia Stephenson; Dorit Ben Shachar
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

8.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

9.  Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease.

Authors:  Fábio B Mury; Weber C da Silva; Nádia R Barbosa; Camila T Mendes; Juliana S Bonini; Jorge Eduardo Souza Sarkis; Martin Cammarota; Ivan Izquierdo; Wagner F Gattaz; Emmanuel Dias-Neto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-12-11       Impact factor: 5.270

10.  Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.

Authors:  Kei Watase; Jennifer R Gatchel; Yaling Sun; Effat Emamian; Richard Atkinson; Ronald Richman; Hidehiro Mizusawa; Harry T Orr; Chad Shaw; Huda Y Zoghbi
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

View more
  28 in total

Review 1.  Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations.

Authors:  B Grant; J A Salpekar
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

2.  Association Between Groundwater Lithium and the Diagnosis of Bipolar Disorder and Dementia in the United States.

Authors:  William F Parker; Rebecca J Gorges; Y Nina Gao; Yudong Zhang; Kwan Hur; Robert D Gibbons
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

3.  Nested exposure case-control sampling: a sampling scheme to analyze rare time-dependent exposures.

Authors:  Jan Feifel; Madlen Gebauer; Martin Schumacher; Jan Beyersmann
Journal:  Lifetime Data Anal       Date:  2018-11-13       Impact factor: 1.588

4.  PRESIDENT'S ADDRESS: WINE, WATER, AND WELLNESS.

Authors:  Ronald A Sacher
Journal:  Trans Am Clin Climatol Assoc       Date:  2019

Review 5.  Trace lithium and mental health.

Authors:  Nobuyoshi Ishii; Takeshi Terao
Journal:  J Neural Transm (Vienna)       Date:  2017-12-12       Impact factor: 3.575

6.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 7.  Pharmacological treatment of adult bipolar disorder.

Authors:  Ross J Baldessarini; Leonardo Tondo; Gustavo H Vázquez
Journal:  Mol Psychiatry       Date:  2018-04-20       Impact factor: 15.992

8.  Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers.

Authors:  Nicholas G Norwitz; Nabeel Saif; Ingrid Estrada Ariza; Richard S Isaacson
Journal:  Nutrients       Date:  2021-04-19       Impact factor: 5.717

Review 9.  Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.

Authors:  Germán Plascencia-Villa; George Perry
Journal:  Antioxid Redox Signal       Date:  2020-07-17       Impact factor: 8.401

Review 10.  Repurposing Licensed Drugs for Use Against Alzheimer's Disease.

Authors:  Leslie C Norins
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.